Web-Based Cognitive Behavior Therapy for Chronic Pain Patients with Aberrant Drug-Related Behavior: Outcomes from a Randomized Controlled Trial
Overview
Neurology
Psychiatry
Authors
Affiliations
Objective: There is high unmet need for effective behavioral treatments for chronic pain patients at risk for or with demonstrated histories of opioid misuse. Despite growing evidence supporting technology-based delivery of self-management interventions for chronic pain, very few such programs target co-occurring chronic pain and aberrant drug-related behavior. This randomized controlled trial evaluated the effectiveness of a novel, web-based self-management intervention, grounded in cognitive behavior therapy, for chronic pain patients with aberrant drug-related behavior.
Methods: Opioid-treated chronic pain patients at a specialty pain practice who screened positive for aberrant drug-related behavior (N = 110) were randomized to receive treatment as usual plus the web-based program or treatment as usual alone. The primary outcomes of pain severity, pain interference, and aberrant drug-related behavior, and the secondary outcomes of pain catastrophizing and pain-related emergency department visits, were assessed during the 12-week intervention and at one and three months postintervention.
Results: Patients assigned to use the web-based program reported significantly greater reductions in aberrant drug-related behavior, pain catastrophizing, and pain-related emergency department visits-but not pain severity or pain interference-relative to those assigned to treatment as usual. The positive outcomes were observed during the 12-week intervention and for three months postintervention.
Conclusions: A web-based self-management program, when delivered in conjunction with standard specialty pain treatment, was effective in reducing chronic pain patients' aberrant drug-related behavior, pain catastrophizing, and emergency department visits for pain. Technology-based self-management tools may be a promising therapeutic approach for the vulnerable group of chronic pain patients who have problems managing their opioid medication.
Yamin J, Pester B, Kommu R, Allen C, Dharmendran D, Steinhilber K Contemp Clin Trials. 2024; 149:107785.
PMID: 39719249 PMC: 11788048. DOI: 10.1016/j.cct.2024.107785.
Stanger C, Anderson M, Xie H, Nnaka T, Budney A, Qian T Psychol Addict Behav. 2024; 39(2):200-211.
PMID: 39418443 PMC: 11875986. DOI: 10.1037/adb0001029.
Edwards K, Palenski P, Perez L, You D, Ziadni M, Jung C BMJ Open. 2024; 14(8):e086889.
PMID: 39122392 PMC: 11332006. DOI: 10.1136/bmjopen-2024-086889.
Klein M, Darnall B, You D JMIR Res Protoc. 2024; 13:e53784.
PMID: 38843513 PMC: 11190622. DOI: 10.2196/53784.
Marier-Deschenes P, Pinard A, Jalbert L, Leblanc A JMIR Hum Factors. 2024; 11:e50747.
PMID: 38701440 PMC: 11102036. DOI: 10.2196/50747.